Cell Therapy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Cell Therapy stocks.

Cell Therapy Stocks Recent News

Date Stock Title
May 20 LSTA Sector Update: Health Care Stocks Softer Late Afternoon
May 20 NKGN Dow Falls Over 150 Points; Sohu Posts Q1 Loss
May 20 NKGN Nasdaq Surges 100 Points; Wix.com Shares Jump Following Q1 Results
May 20 LSTA Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines Agency for Certepetide in Pancreatic Cancer
May 20 NKGN NKGen Biotech’s SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical Trial in Alzheimer’s Disease
May 18 LGVN Longeveron Inc. (LGVN) Q1 2024 Earnings Call Transcript
May 16 NKGN NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International Cell & Gene Therapy China Summit & Exhibition
May 15 MRKR Marker Therapeutics GAAP EPS of -$0.27 misses by $0.02, revenue of $1.24M
May 15 MRKR Marker Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
May 15 LGVN Longeveron GAAP EPS of -$1.61 beats by $0.39, revenue of $0.55M beats by $0.49M
May 15 LGVN LGVN Making Great Strides
May 14 LGVN Longeveron Announces First Quarter 2024 Financial Results and Provides Business Update
May 14 INKT MiNK Therapeutics, Inc. (INKT) Q1 2024 Earnings Call Transcript
May 14 INKT MiNK Therapeutics reports Q1 results
May 14 LEGN Legend Biotech's Carvykti Faces Stiff Challenges Despite Advances
May 14 INKT MiNK Reports First Quarter 2024 Results
May 14 LEGN Legend Biotech Corp (LEGN) Q1 2024 Earnings Call Transcript Highlights: Soaring CARVYKTI Sales ...
Cell Therapy

Cell therapy (also called cellular therapy or cytotherapy) is therapy in which cellular material is injected into a patient; this generally means intact, living cells. For example, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy.
Cell therapy originated in the nineteenth century when scientists experimented by injecting animal material in an attempt to prevent and treat illness. Although such attempts produced no positive benefit, further research found in the mid twentieth century that human cells could be used to help prevent the human body rejecting transplanted organs, leading in time to successful bone marrow transplantation.Today two distinct categories of cell therapy are recognized.The first category is cell therapy in mainstream medicine. This is the subject of intense research and the basis of potential therapeutic benefit. Such research can be controversial when it involves human embryonic material.
The second category is in alternative medicine, and perpetuates the practice of injecting animal materials in an attempt to cure disease. This practice, according to the American Cancer Society, is not backed by any medical evidence of effectiveness, and can have deadly consequences.

Browse All Tags